DK3572405T3 - Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer - Google Patents
Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer Download PDFInfo
- Publication number
- DK3572405T3 DK3572405T3 DK19185319.1T DK19185319T DK3572405T3 DK 3572405 T3 DK3572405 T3 DK 3572405T3 DK 19185319 T DK19185319 T DK 19185319T DK 3572405 T3 DK3572405 T3 DK 3572405T3
- Authority
- DK
- Denmark
- Prior art keywords
- benzoimidazole
- amides
- channel activators
- activators
- channel
- Prior art date
Links
- 239000012190 activator Substances 0.000 title 1
- 150000001408 amides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462050023P | 2014-09-12 | 2014-09-12 | |
| EP15840730.4A EP3191457B1 (en) | 2014-09-12 | 2015-09-14 | BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3572405T3 true DK3572405T3 (da) | 2023-10-16 |
Family
ID=55454102
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19185319.1T DK3572405T3 (da) | 2014-09-12 | 2015-09-14 | Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer |
| DK15840730.4T DK3191457T3 (da) | 2014-09-12 | 2015-09-14 | BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15840730.4T DK3191457T3 (da) | 2014-09-12 | 2015-09-14 | BENZOIMIDAZOL-1,2-YL AMIDER SOM Kv7-KANALAKTIVATORER |
Country Status (14)
| Country | Link |
|---|---|
| US (6) | US9481653B2 (da) |
| EP (3) | EP4289822A3 (da) |
| DK (2) | DK3572405T3 (da) |
| ES (2) | ES2960991T3 (da) |
| FI (1) | FI3572405T3 (da) |
| HR (1) | HRP20231071T1 (da) |
| HU (1) | HUE064331T2 (da) |
| LT (1) | LT3572405T (da) |
| PL (1) | PL3572405T3 (da) |
| PT (1) | PT3572405T (da) |
| RS (1) | RS64708B1 (da) |
| SI (1) | SI3572405T1 (da) |
| SM (1) | SMT202300362T1 (da) |
| WO (2) | WO2016040952A2 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2970277B1 (en) * | 2013-03-15 | 2021-07-28 | Knopp Biosciences LLC | Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators |
| SMT202300362T1 (it) | 2014-09-12 | 2023-11-13 | Biohaven Therapeutics Ltd | Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7 |
| ES3032221T3 (en) * | 2018-02-20 | 2025-07-16 | H Lundbeck As | Alcohol derivatives as kv7 potassium channel openers |
| US10590067B2 (en) | 2018-02-20 | 2020-03-17 | H. Lundbeck A/S | Alcohol derivatives of carboxamides as Kv7 potassium channel openers |
| CA3093976A1 (en) * | 2018-03-19 | 2019-09-26 | Michael E. Bozik | Kv7 channel activators compositions and methods of use |
| MX2022001063A (es) * | 2019-08-02 | 2022-02-14 | H Lundbeck As | Derivados de alcohol como abridores del canal de potasio kv7. |
| JP7591036B2 (ja) | 2019-08-02 | 2024-11-27 | ハー・ルンドベック・アクチエゼルスカベット | てんかん又はてんかん発作において使用するためのＫｖ７カリウムチャネル開口薬としてのアルコール誘導体 |
| AR119521A1 (es) | 2019-08-02 | 2021-12-22 | H Lundbeck As | DERIVADOS DE ALCOHOL COMO ABRIDORES DEL CANAL DE POTASIO Kv7 |
| US20220227716A1 (en) * | 2019-08-28 | 2022-07-21 | Ferro Therapeutics, Inc. | Benzimidazole and hydrogenated carbazole derivatives as gpx4 inhibitors |
| EP4031548A4 (en) * | 2019-09-17 | 2023-10-18 | Knopp Biosciences LLC | Methods of use for kv7 channel activators |
| WO2023133256A1 (en) * | 2022-01-07 | 2023-07-13 | Biohaven Therapeutics Ltd. | Pyrazolo[1,5-a]pyridin-2,3-yl amides as kv7 channel activators |
| EP4584250A4 (en) * | 2022-09-06 | 2026-02-25 | Biohaven Therapeutics Ltd | POLYTHERAPIES INCLUDING METAL CHANNEL ACTIVATORS |
| WO2025103406A1 (zh) * | 2023-11-15 | 2025-05-22 | 南京明德新药研发有限公司 | 6并5杂芳基衍生物及其应用 |
| WO2026042005A1 (en) | 2024-08-18 | 2026-02-26 | Biohaven Therapeutics Ltd. | Prodrugs of benzimidazol-1,2-yl amide compounds |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1022554A (en) | 1973-03-07 | 1977-12-13 | Haukur Kristinsson | 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines |
| US4002623A (en) | 1974-08-07 | 1977-01-11 | Pfizer Inc. | Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines |
| ES473201A1 (es) | 1977-09-26 | 1979-03-16 | Degussa | Procedimiento para la preparacion de 7-azabencimidazoles |
| US4391811A (en) | 1981-10-02 | 1983-07-05 | Sterling Drug Inc. | 2-Amino-6-(pyridinyl)-3H-imidazo[4,5-b]pyridines and their cardiotonic use |
| JPH0772181B2 (ja) * | 1989-06-26 | 1995-08-02 | 株式会社大塚製薬工場 | ベンズイミダゾール誘導体 |
| JPH0772181A (ja) | 1993-09-03 | 1995-03-17 | Advantest Corp | 電位波形測定方法および装置 |
| GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
| KR100547929B1 (ko) | 1997-09-26 | 2006-02-02 | 젠타리스 게엠베하 | 세린/트레오닌 단백질 키나제 기능을 조절하기 위한 아자벤즈이미다졸계 화합물, 이의 제조방법 및 이를 포함하는 약제학적 조성물 |
| US20030109549A1 (en) * | 1999-08-05 | 2003-06-12 | Fumitaka Ito | 2-Substituted-1-piperidyl benzimidazole compounds as ORL1-receptor agonists |
| JP2001199968A (ja) | 2000-01-18 | 2001-07-24 | Teijin Ltd | アミノベンズイミダゾール誘導体 |
| US6384049B1 (en) | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
| US6855714B2 (en) * | 2001-07-06 | 2005-02-15 | Schering Aktiengesellschaft | 1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| FR2846656B1 (fr) | 2002-11-05 | 2004-12-24 | Servier Lab | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| SE0301701D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| WO2005021547A2 (en) | 2003-08-28 | 2005-03-10 | Pharmaxis Pty Ltd. | Heterocyclic cannabinoid cb2 receptor antagonists |
| KR20070092297A (ko) | 2004-12-21 | 2007-09-12 | 데브젠 엔브이 | Ｋｖ4 이온 채널 활성을 갖는 화합물 |
| US20080146536A1 (en) | 2005-08-16 | 2008-06-19 | Pharmacopeia, Inc. | 2-Aminoimidazopyridines for treating neurodegenerative diseases |
| ES2274712B1 (es) | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| US8288393B2 (en) | 2007-08-10 | 2012-10-16 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic compound and pest control agent |
| EP2178373B1 (en) | 2007-08-17 | 2013-01-23 | Icagen, Inc. | Heterocycles as potassium channel modulators |
| JP5479912B2 (ja) * | 2007-11-22 | 2014-04-23 | 全薬工業株式会社 | 複素環式化合物の非晶質体、それを含む固体分散体、薬剤、およびその製造法 |
| GB0723794D0 (en) | 2007-12-05 | 2008-01-16 | Lectus Therapeutics Ltd | Potassium ion channel modulators and uses thereof |
| JP5520831B2 (ja) * | 2007-12-19 | 2014-06-11 | アムジエン・インコーポレーテツド | Ｐｉ３キナーゼの阻害薬 |
| US20110269783A1 (en) * | 2008-11-10 | 2011-11-03 | Neurosearch A/S | Novel 2,3-diamino-quinazolinone derivatives and their medical use |
| PE20120334A1 (es) * | 2008-12-19 | 2012-04-16 | Abbott Lab | COMPUESTOS HETEROCICLICOS INHIBIDORES DE LAS PROTEINAS ANTI-APOPTOTICAS Bcl2 |
| WO2010094645A1 (en) | 2009-02-17 | 2010-08-26 | Neurosearch A/S | Substituted pyridine derivatives and their medical use |
| WO2011051452A1 (en) | 2009-10-29 | 2011-05-05 | Palau Pharma, S.A. | N-containing heteroaryl derivatives as jak3 kinase inhibitors |
| WO2012003576A1 (en) | 2010-07-06 | 2012-01-12 | Université de Montréal | Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| US8883812B2 (en) * | 2010-07-08 | 2014-11-11 | Pfizer Inc. | Piperidinyl pyrimidine amides as Kv7 potassium channel openers |
| MX2013001313A (es) * | 2010-08-05 | 2013-06-13 | Amgen Inc | Compuestos de bencimidazol y azabencimidazol que inhiben la cinasa del linfoma anaplasico. |
| EP2970277B1 (en) | 2013-03-15 | 2021-07-28 | Knopp Biosciences LLC | Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators |
| SMT202300362T1 (it) * | 2014-09-12 | 2023-11-13 | Biohaven Therapeutics Ltd | Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7 |
| CA3093976A1 (en) * | 2018-03-19 | 2019-09-26 | Michael E. Bozik | Kv7 channel activators compositions and methods of use |
| EP4031548A4 (en) * | 2019-09-17 | 2023-10-18 | Knopp Biosciences LLC | Methods of use for kv7 channel activators |
-
2015
- 2015-09-14 SM SM20230362T patent/SMT202300362T1/it unknown
- 2015-09-14 HU HUE19185319A patent/HUE064331T2/hu unknown
- 2015-09-14 ES ES19185319T patent/ES2960991T3/es active Active
- 2015-09-14 SI SI201531964T patent/SI3572405T1/sl unknown
- 2015-09-14 HR HRP20231071TT patent/HRP20231071T1/hr unknown
- 2015-09-14 EP EP23182255.2A patent/EP4289822A3/en active Pending
- 2015-09-14 DK DK19185319.1T patent/DK3572405T3/da active
- 2015-09-14 LT LTEP19185319.1T patent/LT3572405T/lt unknown
- 2015-09-14 RS RS20230951A patent/RS64708B1/sr unknown
- 2015-09-14 PL PL19185319.1T patent/PL3572405T3/pl unknown
- 2015-09-14 DK DK15840730.4T patent/DK3191457T3/da active
- 2015-09-14 ES ES15840730T patent/ES2749103T3/es active Active
- 2015-09-14 PT PT191853191T patent/PT3572405T/pt unknown
- 2015-09-14 US US14/853,815 patent/US9481653B2/en active Active
- 2015-09-14 FI FIEP19185319.1T patent/FI3572405T3/fi active
- 2015-09-14 WO PCT/US2015/050027 patent/WO2016040952A2/en not_active Ceased
- 2015-09-14 EP EP15840730.4A patent/EP3191457B1/en active Active
- 2015-09-14 EP EP19185319.1A patent/EP3572405B9/en active Active
-
2016
- 2016-10-31 US US15/339,590 patent/US9914708B2/en active Active
-
2017
- 2017-10-31 WO PCT/US2017/059393 patent/WO2018081825A1/en not_active Ceased
-
2018
- 2018-01-25 US US15/879,792 patent/US10385025B2/en active Active
-
2019
- 2019-07-02 US US16/460,449 patent/US10906877B2/en active Active
-
2020
- 2020-12-18 US US17/127,231 patent/US11834418B2/en active Active
-
2023
- 2023-10-20 US US18/490,942 patent/US12351559B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3572405T3 (da) | Benzoimidazol-1,2-yl-amider som kv7-kanalaktivatorer | |
| LT3230281T (lt) | 1,3-tiazol-2-ilu pakeisti benzamidai | |
| DK3352625T3 (da) | Reorganiserbar liggestol til flere formål, flere anvendelser | |
| BR112017012364A2 (pt) | pré-tratamento rápido. | |
| CL2014003447S1 (es) | Refrigerador. | |
| ZA201703498B (en) | Kcnq2-5 channel activator | |
| DK3158847T3 (da) | Bæreanordning | |
| LT3253749T (lt) | Junginiai, pasižymintys priešnavikiniu aktyvumu | |
| LT3233862T (lt) | Imidazopiridazino dariniai, kaip pi3kbeta slopikliai | |
| DK3204357T3 (da) | Fluorescerende, syntetiske retinoider | |
| DK3250774T3 (da) | Port, især hurtigt løbende port | |
| BR112016030583A2 (pt) | corante microambiente | |
| EP3146119C0 (de) | Pneumatischer träger | |
| ES1141490Y (es) | Mochila | |
| EP3284795A4 (en) | NUCLEAR ACTIVATOR WITH FREEZER PROTECTION | |
| ES1147033Y (es) | Mochila adaptable | |
| DK3448845T3 (da) | Substituerede 2-alkylimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
| EP3317561A4 (en) | DUAL MODE JIG | |
| UA31600S (uk) | Рюкзак | |
| UA31599S (uk) | Рюкзак | |
| TH1601002675B (th) | ชิ้นส่วนรองลื่นแบบเลื่อน | |
| TH1601002676B (th) | ชิ้นส่วนรองลื่นเเบบเลื่อน | |
| LT3110812T (lt) | Anti-amiloidų junginiai, turintys benzofurazano | |
| UA30065S (uk) | Рюкзак | |
| ES1148485Y (es) | Mochila mejorada |